Discussion about this post

User's avatar
Steve Brecher's avatar

"The shingles vaccine" is ambiguous. The cited study used a live-attenuated herpes zoster vaccine. It says, "our results pertain to the live-attenuated HZ vaccine (Zostavax, Merck) only, because the newer recombinant HZ vaccine (Shingrix, GSK) was introduced into the UK’s National Health Service after our follow-up period ended." Zostavax was discontinued in the U.S. in 1920.

Expand full comment
1 more comment...

No posts

Ready for more?